1. Regioisomeric family of novel fluorescent substrates for SHIP2
- Author
-
Stephen J Mills, Vasily S. Oganesyan, Gaye F. White, Christopher Prior, Kendall Baker, Hayley Whitfield, Barry V. L. Potter, Andrew M. Riley, and Charles A. Brearley
- Subjects
Letter ,5-phosphatase ,ligand ,01 natural sciences ,Biochemistry ,chemistry.chemical_compound ,Drug Discovery ,Inositol ,Inositol phosphate ,PI3K/AKT/mTOR pathway ,chemistry.chemical_classification ,biology ,010405 organic chemistry ,Organic Chemistry ,Rational design ,Active site ,Ligand (biochemistry) ,SHIP2 ,Fluorescence ,Small molecule ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,chemistry ,biology.protein ,fluorescence ,HPLC ,TD-DFT - Abstract
SHIP2 (SH2-domain containing inositol 5-phosphatase type 2) is a canonical 5-phosphatase, which, through its catalytic action on PtdInsP3, regulates the PI3K/Akt pathway and metabolic action of insulin. It is a drug target, but there is limited evidence of inhibition of SHIP2 by small molecules in the literature. With the goal to investigate inhibition, we report a homologous family of synthetic, chromophoric benzene phosphate substrates of SHIP2 that display the headgroup regiochemical hallmarks of the physiological inositide substrates that have proved difficult to crystallize with 5-phosphatases. Using time-dependent density functional theory (TD-DFT), we explore the intrinsic fluorescence of these novel substrates and show how fluorescence can be used to assay enzyme activity. The TD-DFT approach promises to inform rational design of enhanced active site probes for the broadest family of inositide-binding/metabolizing proteins, while maintaining the regiochemical properties ofbona fideinositide substrates.
- Published
- 2020